1. Home
  2. LILA vs AUPH Comparison

LILA vs AUPH Comparison

Compare LILA & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liberty Latin America Ltd.

LILA

Liberty Latin America Ltd.

N/A

Current Price

$9.17

Market Cap

1.8B

ML Signal

N/A

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

N/A

Current Price

$14.77

Market Cap

2.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LILA
AUPH
Founded
2017
1993
Country
Bermuda
Canada
Employees
N/A
N/A
Industry
Cable & Other Pay Television Services
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.2B
IPO Year
2017
2014

Fundamental Metrics

Financial Performance
Metric
LILA
AUPH
Price
$9.17
$14.77
Analyst Decision
Hold
Buy
Analyst Count
3
6
Target Price
$10.55
★ $18.50
AVG Volume (30 Days)
401.0K
★ 841.2K
Earning Date
11-04-2026
10-30-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 7.55
N/A
EPS
N/A
★ 0.76
Revenue
★ $4,442,200,000.00
$283,055,000.00
Revenue This Year
$0.60
$16.65
Revenue Next Year
$2.80
$17.73
P/E Ratio
★ N/A
$19.58
Revenue Growth
N/A
★ N/A
52 Week Low
$4.77
$13.52
52 Week High
$10.33
$19.25

Technical Indicators

Market Signals
Indicator
LILA
AUPH
Relative Strength Index (RSI) 51.38 30.55
Support Level $7.27 $14.38
Resistance Level $10.33 $15.15
Average True Range (ATR) 0.50 0.50
MACD -0.00 -0.20
Stochastic Oscillator 46.26 3.61

Price Performance

Historical Comparison
LILA
AUPH

About LILA Liberty Latin America Ltd.

Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Share on Social Networks: